Germany 3D Imaging Market Analysis Report 2022 to 2030

Germany 3D Imaging Market Analysis

$ 3999

Germany's 3D imaging market is projected to grow from $1.11 Bn in 2022 to $3.33 Bn by 2030, registering a CAGR of 14.7% during the forecast period of 2022-30. The market will be driven by technological advancements, an increase in the frequency of chronic diseases & rising demand for less invasive treatments. The market is segmented by product, application, by end-user & by portability. Some of the major players include Siemens Healthineers, Philips Healthcare & Carl Zeiss Meditec.

ID: IN10DEDH001 CATEGORY: Digital Health GEOGRAPHY: Germany AUTHOR: Vidhi Upadhyay

Buy Now

Germany 3D Imaging Market Executive Summary

Germany's 3D imaging market is projected to grow from $1.11 Bn in 2022 to $3.33 Bn by 2030, registering a CAGR of 14.7% during the forecast period of 2022-30. Germany has one of the highest healthcare spending as a percentage of Gross Domestic Product (GDP) among developed countries. Germany spent 12.8% of its GDP on healthcare in the year 2021 as compared to 11.7% in 2019. The government initiated the annual federal grant to the umbrella health fund and direct subsidies to fight the COVID–19 pandemic. According to Globocan 2020, the number of new cases of cancer was 6,28,519 with Breast cancer contributing to 11.1%, prostate cancer at 10.8%, and Lung cancer at 10.3% of the same.

The 3D imaging market in Germany is a rapidly expanding business with great development potential. Germany is one of Europe's major markets for imaging equipment, and demand for 3D imaging systems such as CT scans and MRI scanners has increased in recent years. The German government has also made investments in healthcare, especially in the development of cutting-edge imaging technology. This has resulted in the emergence of local firms specializing in the development and manufacture of 3D imaging equipment, which has boosted the industry even more.

germany 3D imaging market analysis

Market Dynamics

Market Growth Drivers

The 3D imaging market in Germany is expanding due to a variety of factors such as technological improvements, an increase in the frequency of chronic diseases, rising demand for less invasive treatments, government support for the growth of increasingly advanced and precise 3D imaging technologies aids in the detection and treatment of illnesses such as cancer, cardiovascular disease, and neurological disorders. The German government has aggressively supported the healthcare industry, which has resulted in increased investment in the development of 3D imaging technologies. Demand for 3D imaging devices that can offer comprehensive pictures of biological tissues and structures. These factors are projected to drive the future growth of the 3D imaging market in Germany.

Market Restraints

3D imaging technologies are frequently more expensive than standard imaging systems, making them less accessible to some healthcare practitioners and patients. The lack of market standardization makes it difficult for healthcare practitioners to pick between different systems. Reimbursement regulations for 3D imaging systems can also be tight, restricting investment in these technologies. Furthermore, there is a scarcity of skilled staff who can run and maintain these devices. Data privacy issues may make some healthcare practitioners and patients hesitant to utilize 3D imaging technologies. These factors are projected to limit the growth of the 3D imaging market in Germany in the future.

Competitive Landscape

Key Players

Siemens Healthineers
Philips Healthcare
GE Healthcare
Hitachi Medical Systems
Toshiba Medical Systems
Carl Zeiss Meditec (DEU)
Barco (DEU)

Notable Deals

In February 2023, Philips joined the European Federation for Cancer Images (EUCAIM) to enhance precision medicine for cancer patients in Europe
July 2022, Siemens Healthineers at the European Congress of Radiology (ECR) in Vienna, unveiled its most economical X-ray equipment to date. The system is intended to provide more access to care

Healthcare Policies and Regulatory Landscape

The Federal Institute for Drugs and Medical Devices (BfArM) is Germany's healthcare and medical device regulating organization. This organization is in charge of ensuring that medical products, particularly 3D imaging systems, satisfy the safety, quality, and performance criteria. Medical devices in Germany are governed by the Medical Equipment Act (MPG) and the Medical Devices Regulation (MDR), which are intended to assure the safety and performance of medical devices such as 3D imaging systems.

There are additional European Union (EU) rules that apply to medical devices, such as the Medical Devices Directive (MDD) and the In Vitro Diagnostic Devices Regulation (IVDR). These laws seek to standardize medical device regulation across the EU.

Reimbursement Scenario

In Germany, reimbursement for 3D imaging is mostly supplied through the statutory health insurance system. This system serves the majority of the population and is supported by employee, employer, and government payments. If 3D imaging operations are considered medically essential and match the standards stipulated by the statutory health insurance funds, they are compensated. This might include factors linked to the patient's health, the availability of alternative therapies, and the procedure's clinical and cost-effectiveness.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.